Get started
Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026

Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026

No trades
See on Supercharts
Overview
Analysis

ICPT5464611 chart


Full chart

Key terms


Outstanding amount
‪60.00 K‬USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
3.50% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
−2.08%
Maturity date
Feb 15, 2026
Term to maturity
1 year

About Intercept Pharmaceuticals, Inc. 3.5% 15-FEB-2026


Issuer
Intercept Pharmaceuticals, Inc.
Sector
Health Technology
Home page
interceptpharma.com
Issue date
Aug 18, 2022
FIGI
BBG01239DFQ5
Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in Morristown, NJ.

Analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.